Abstract Details
|
Emer McGrath, MBChB
(HRB Clinical Research Facility, University of Galway)
PRESENTER |
Dr. McGrath has nothing to disclose. |
| Jayandra Himali | Jayandra Himali has nothing to disclose. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Alexa Beiser | Alexa Beiser has nothing to disclose. |
| No disclosure on file | |
| Claudia L. Satizabal, PhD (UT Health San Antonio) | The institution of Dr. Satizabal has received research support from NIH and TARCC. |
| Matthew Pase, PhD (Monash University) | Dr. Pase has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzheimer's Disease Drug Discovery Foundation. |
| No disclosure on file | |
| Sudha Seshadri, MD, FAAN (Glenn Biggs Institute for Alzheimer'S and Neurodegenerative Diseases) | Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association. |